# Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

> **NCT04293289** · NA · COMPLETED · sponsor: **Cancer Intelligence Care Systems, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Malignant Melanoma
- Angiosarcoma

## Interventions

- **OTHER:** CICS-1 (investigational device),SPM-011(investigational drug)

## Key facts

- **NCT ID:** NCT04293289
- **Lead sponsor:** Cancer Intelligence Care Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-19
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04293289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04293289, "Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04293289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*